Replies to post #72220 on Biotech Values

[DewDiligence]

It doesn't seem to me that wye extracted any decent premium if you were to consider that bap could be the "biggest" drug ever.

The Bap vig, such as it is, was already in WYE’s pre-deal share price.

[masterlongevity]

i suggest you re-review the bapinezumab ph 2 study design and data. it is being valued as worth zero by the market and pfe